Long-term trajectory of two unique cardiac biomarkers and subsequent left ventricular structural pathology and risk of incident heart failure in community-dwelling older adults at low baseline risk

JACC: Heart Failure

Volumn 1, Issue 4, 2013, Pages 353-360

  Glick, Danielle ^a   deFilippi, Christopher R ^a   Christenson, Robert ^a   Gottdiener, John S ^a   Seliger, Stephen L ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Elderly; Epidemiology; NT proBNP; Troponin

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; TROPONIN T;

AGED; ARTICLE; COHORT ANALYSIS; COMMUNITY LIVING; ECHOCARDIOGRAPHY; FEMALE; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SYSTOLIC DYSFUNCTION;

ELDERLY; EPIDEMIOLOGY; NT-PROBNP; TROPONIN;

AGED; BIOLOGICAL MARKERS; FEMALE; HEART FAILURE; HEART VENTRICLES; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; TIME FACTORS; TROPONIN T;

EID: 84883591288     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2013.04.007     Document Type: Article

References (31)

1. Roger V.L., Go A.S., Lloyd-Jones D.M., et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011, 123:e18-e209.
2. D'Agostino R.B., Grundy S., Sullivan L.M., Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001, 286:180-187.
3. Koller M.T., Leening M.J.G., Wolbers M., et al. Development and validation of a coronary risk prediction model for older U.S. and European persons in the Cardiovascular Health Study and the Rotterdam Study. Ann Intern Med 2012, 157:389-397.
4. Blankenberg S., Zeller T., Saarela O., et al. Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, Risk, Genetics, Archiving, and Monograph (MORGAM) Biomarker Project. Circulation 2010, 121:2388-2397.
5. deFilippi C.R., Christenson R.H., Gottdiener J.S., Kop W.J., Seliger S.L. Dynamic cardiovascular risk assessment in elderly people: the role of repeated N-terminal pro-B-type natriuretic peptide testing. JAm Coll Cardiol 2010, 55:441-450.
6. deFilippi C.R., de Lemos J.A., Christenson R.H., et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA 2010, 304:2494-2502.
7. Saunders J.T., Nambi V., de Lemos J.A., et al. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation 2011, 123:1367-1376.
8. Wang T.J. Multiple biomarkers for predicting cardiovascular events: lessons learned. JAm Coll Cardiol 2010, 55:2092-2095.
9. Zethelius B., Berglund L., Sundstrom J., et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. NEngl J Med 2008, 358:2107-2116.
10. Smith J.G., Newton-Cheh C., Almgren P., et al. Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation. JAm Coll Cardiol 2010, 56:1712-1719.
11. Fried L.P., Borhani N.O., Enright P., et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol 1991, 1:263-276.
12. Ives D.G., Fitzpatrick A.L., Bild D.E., et al. Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. Ann Epidemiol 1995, 5:278-285.
13. Schellenbaum G.D., Heckbert S.R., Smith N.L., et al. Congestive heart failure incidence and prognosis: case identification using central adjudication versus hospital discharge diagnoses. Ann Epidemiol 2006, 16:115-122.
14. Gardin J.M., Wong N.D., Bommer W., et al. Echocardiographic design of a multicenter investigation of free-living elderly subjects: the Cardiovascular Health Study. JAm Soc Echocardiogr 1992, 5:63-72.
15. de Simone G., Daniels S.R., Devereux R.B., et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. JAm Coll Cardiol 1992, 20:1251-1260.
16. Giannitsis E., Kurz K., Hallermayer K., Jarausch J., Jaffe A.S., Katus H.A. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010, 56:254-261.
17. de Lemos J.A., Drazner M.H., Omland T., et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010, 304:2503-2512.
18. Schou M., Gustafsson F., Kjaer A., Hildebrandt P.R. Long-term clinical variation of NT-proBNP in stable chronic heart failure patients. Eur Heart J 2007, 28:177-182.
19. Wu A.H.B., Lu Q.A., Todd J., Moecks J., Wians F. Short- and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice. Clin Chem 2009, 55:52-58.
20. Kalogeropoulos A., Psaty B.M., Vasan R.S., Georgiopoulou V., et al. Validation of the health ABC heart failure model for incident heart failure risk prediction: the Cardiovascular Health Study. Circ Heart Fail 2010, 3:495-502.
21. Pencina M.J., D'Agostino R.B., Larson M.G., Massaro J.M., Vasan R.S. Predicting the 30-year risk of cardiovascular disease: the Framingham Heart Study. Circulation 2009, 119:3078-3084.
22. Heagerty P.J., Lumley T., Pepe M.S. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 2000, 56:337-344.
23. Pencina M.J., D'Agostino R.B., D'Agostino R.B., Vasan R.S. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008, 27:157-172. discussion 207-12.
24. Pencina M.J., D'Agostino R.B., Steyerberg E.W. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 2011, 30:11-21.
25. Nadir M.A., Rekhraj S., Wei L., et al. Improving the primary prevention of cardiovascular events by using biomarkers to identify individuals with silent heart disease. JAm Coll Cardiol 2012, 60:960-968.
26. Owan T.E., Hodge D.O., Herges R.M., Jacobsen S.J., Roger V.L., Redfield M.M. Trends in prevalence and outcome of heart failure with preserved ejection fraction. NEngl J Med 2006, 355:251-259.
27. Aurigemma G.P., Gottdiener J.S., Shemanski L., Gardin J., Kitzman D. Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the cardiovascular health study. JAm Coll Cardiol 2001, 37:1042-1048.
28. Schelbert E.B., Cao J.J., Sigurdsson S., et al. Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults. JAMA 2012, 308:890-896.
29. Jenkins C., Bricknell K., Hanekom L., Marwick T.H. Reproducibility and accuracy of echocardiographic measurements of left ventricular parameters using real-time three-dimensional echocardiography. JAm Coll Cardiol 2004, 44:878-886.
30. Cook N.R. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 2007, 115:928-935.
31. deFilippi C.R., Seliger S.L. Biomarkers for prognostication after acute coronary syndromes: new times and statistics. JAm Coll Cardiol 2009, 54:365-367.